By 2033, the global aesthetics market is projected to jump to US$14.7 billion, but the bigger surprise for medspa operators is how fast “aesthetic medical services” are expected to scale to US$23.3 billion by 2030. Patient satisfaction is high and complication rates are generally low, yet reviews, claims volume, and even financing decisions are shaping demand in ways that don’t show up in growth charts. Here are the metrics medspas should track side by side to understand where revenue actually comes from.
Key Takeaways
- US$6.5 billion global aesthetics market size in 2023, projected to reach US$14.7 billion by 2033.
- $10.9 billion global market size for aesthetic medical services in 2023, projected to reach $23.3 billion by 2030.
- 8.2% estimated CAGR for the global medical aesthetics market from 2024 to 2032 (growth rate used in forecast).
- 82% of patients reported satisfaction with their results in a 2020 systematic review of aesthetic injectables outcomes (pooled satisfaction rate).
- In a 2021 peer-reviewed review, complication rates for minimally invasive aesthetic procedures were reported as generally low, with most studies reporting adverse events in the single-digit percentages.
- A 2019 review found that the most common aesthetic injection complications included bruising, edema, and pain, typically self-limited (proportion data varies by study).
- US FDA: ‘Medical device adverse event reporting’ uses the MAUDE database and is accessible to the public (MAUDE database definition and access).
- 13,500+ dermatologists and 10,000+ plastic surgeons in the US (2023 physician workforce counts for relevant specialties), providing the provider ecosystem that medspas compete for/affiliate with
- 1,020,000+ beauty and personal care workers in the US in 2023 (BLS occupational employment), indicating related workforce availability for salon/medspa service roles
- More than 2.3 million people in the US were employed in outpatient care centers in 2023 per BLS employment data, reflecting the wider setting where aesthetics providers may operate or affiliate
- 42% of surveyed consumers consider reviews 'very important' when choosing a provider for cosmetic procedures, supporting the role of reputation management for medspas
- 19.4% of cosmetic procedures in the US are performed on a financing plan (afterpay/credit) in 2022 survey-based market research, indicating payment flexibility demand
- Google Business Profile actions (calls/messages) were associated with a median 12% increase in appointment requests in 2021 observational analysis for local healthcare providers
- 58% of patients use online search to find cosmetic procedure providers, supporting SEO as a primary acquisition channel in medspa business models
- In a 2020 study of device-related injuries, 6.2% of adverse event reports for aesthetics-adjacent dermatologic procedures involved repeat reports by the same facility, highlighting operational monitoring needs
Medspas are poised for fast growth as patient satisfaction stays high, safety risks are generally low, and demand keeps rising.
Related reading
01 · Category
Market Size6 stats
01
US$6.5 billion global aesthetics market size in 2023, projected to reach US$14.7 billion by 2033.
02
$10.9 billion global market size for aesthetic medical services in 2023, projected to reach $23.3 billion by 2030.
03
8.2% estimated CAGR for the global medical aesthetics market from 2024 to 2032 (growth rate used in forecast).
04
The global wound care market reached $14.5B in 2023 (context for post-procedure care consumables used in medspas; may influence accessory revenue streams).
05
The US Bureau of Labor Statistics reported 2023 employment counts for ‘Offices of Physicians’ and ‘Outpatient Care Centers’ categories that include many aesthetics providers (employment baseline).
06
13.2% estimated CAGR for the global aesthetic medical services market (2023–2030) implying accelerated revenue growth for medspa providers
Interpretation
Market Size Interpretation
The market size for medical aesthetics is set to nearly double over the next decade with the global aesthetics market rising from US$6.5 billion in 2023 to US$14.7 billion by 2033, alongside aesthetic medical services growing from $10.9 billion in 2023 to $23.3 billion by 2030, signaling strong and sustained expansion for medspas across the industry’s market size category.
02 · Category
Industry Trends8 stats
01
82% of patients reported satisfaction with their results in a 2020 systematic review of aesthetic injectables outcomes (pooled satisfaction rate).
02
In a 2021 peer-reviewed review, complication rates for minimally invasive aesthetic procedures were reported as generally low, with most studies reporting adverse events in the single-digit percentages.
03
A 2019 review found that the most common aesthetic injection complications included bruising, edema, and pain, typically self-limited (proportion data varies by study).
04
FDA-approved botulinum toxin type A products are used in multiple indications, with an overall extensive safety database supporting regular use under medical supervision (summary of approval/labeling).
05
In a 2021 study, online reviews significantly affected demand for aesthetic services, with review rating and volume associated with higher conversion rates (quantitative regression results).
06
US inflation-adjusted consumer spending on ‘personal care products’ grew in 2023 compared with 2022 (consumer category trend).
07
8.6% share of US adults reported having had a cosmetic procedure (including non-surgical) in a 2018 survey baseline for aesthetics consumer penetration
08
48% of dermatologists reported they use teledermatology in at least some practice in 2020, relevant because virtual screening can funnel patients into medspa/derm aesthetics
Interpretation
Industry Trends Interpretation
Across current industry trends in aesthetics, patient and provider evidence suggests strong demand and outcomes as 82% of patients reported satisfaction with aesthetic injectables in 2020 and complication rates for minimally invasive procedures were mostly in single-digit percentages, while digital influence is also growing with US teledermatology use at 48% in 2020 and online review ratings driving higher conversion in 2021.
03 · Category
Regulation & Safety1 stats
01
US FDA: ‘Medical device adverse event reporting’ uses the MAUDE database and is accessible to the public (MAUDE database definition and access).
Interpretation
Regulation & Safety Interpretation
For the Regulation and Safety category, the US FDA’s use of the MAUDE database for medical device adverse event reporting offers an unusually transparent public-facing mechanism for tracking safety concerns through accessible adverse event data.
More related reading
04 · Category
Workforce3 stats
01
13,500+ dermatologists and 10,000+ plastic surgeons in the US (2023 physician workforce counts for relevant specialties), providing the provider ecosystem that medspas compete for/affiliate with
02
1,020,000+ beauty and personal care workers in the US in 2023 (BLS occupational employment), indicating related workforce availability for salon/medspa service roles
03
More than 2.3 million people in the US were employed in outpatient care centers in 2023 per BLS employment data, reflecting the wider setting where aesthetics providers may operate or affiliate
Interpretation
Workforce Interpretation
With 13,500+ dermatologists and 10,000+ plastic surgeons plus 1,020,000+ beauty and personal care workers available in the US, the workforce pipeline for aesthetics medspas is unusually deep and supported by adjacent employment beyond the clinic setting, including more than 2.3 million outpatient care center workers in 2023.
05 · Category
Consumer Demand2 stats
01
42% of surveyed consumers consider reviews 'very important' when choosing a provider for cosmetic procedures, supporting the role of reputation management for medspas
02
19.4% of cosmetic procedures in the US are performed on a financing plan (afterpay/credit) in 2022 survey-based market research, indicating payment flexibility demand
Interpretation
Consumer Demand Interpretation
Consumer demand is being driven by trust and payment flexibility, with 42% of surveyed consumers saying reviews are very important and 19.4% of US cosmetic procedures taking place on financing plans in 2022.
06 · Category
Performance Metrics4 stats
01
Google Business Profile actions (calls/messages) were associated with a median 12% increase in appointment requests in 2021 observational analysis for local healthcare providers
02
58% of patients use online search to find cosmetic procedure providers, supporting SEO as a primary acquisition channel in medspa business models
03
In a 2020 study of device-related injuries, 6.2% of adverse event reports for aesthetics-adjacent dermatologic procedures involved repeat reports by the same facility, highlighting operational monitoring needs
04
1.2 million entries of laser/energy-based procedure-related complications were captured in a large claims database study covering 2018–2020, quantifying claims volume for risk assessment
Interpretation
Performance Metrics Interpretation
For medspas, performance metrics show a clear link between marketing and measurable demand, with a median 12% rise in appointment requests tied to Google Business Profile actions in 2021 and 58% of patients using online search to find providers, making SEO and call or message conversions central acquisition drivers.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Thomas Lindqvist. (2026, February 13). Aesthetics Medspa Industry Statistics. Gitnux. https://gitnux.org/aesthetics-medspa-industry-statistics
MLA
Thomas Lindqvist. "Aesthetics Medspa Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/aesthetics-medspa-industry-statistics.
Chicago
Thomas Lindqvist. 2026. "Aesthetics Medspa Industry Statistics." Gitnux. https://gitnux.org/aesthetics-medspa-industry-statistics.
Sources & references
24 datasets cited across this report · attribution is report-level
+8 additional datasets cited (not shown individually)